Tectonic Therapeutic (TECX) Total Current Liabilities (2017 - 2026)
Tectonic Therapeutic (TECX) reported Total Current Liabilities of $13.0 million for Q1 2026, down 4.09% year-over-year from $13.5 million in Q1 2025, and up 34.06% quarter-over-quarter from $9.7 million in Q4 2025.
Tectonic Therapeutic (TECX) Total Current Liabilities (2017 - 2026) Analysis & Trends
Tectonic Therapeutic (TECX) has 10 years of Total Current Liabilities data on file, last reported at $13.0 million in Q1 2026.
- Total Current Liabilities for Q1 2026 came in at $13.0 million, down 4.09% year-over-year; the trailing twelve-month figure through Mar 2026 was $13.0 million (down 4.09% YoY), and the FY2025 annual result was $9.7 million, down 16.74% from the prior year.
- Total Current Liabilities improved to $13.0 million in Q1 2026 per TECX's latest filing, from $9.7 million in the prior quarter.
- Over five years, Total Current Liabilities peaked at $40.9 million in Q4 2023 and troughed at $3.5 million in Q1 2024.
- A 5-year average of $14.6 million and a median of $13.0 million in 2026 frame the typical range for Total Current Liabilities.
- The sharpest annual moves came in 2024 and 2025: Total Current Liabilities tumbled 75.46% in 2024, then jumped 285.01% in 2025.
- A 5-year view of Total Current Liabilities shows it stood at $13.1 million in 2022, then jumped by 211.77% to $40.9 million in 2023, then tumbled by 71.61% to $11.6 million in 2024, then dropped by 16.74% to $9.7 million in 2025, then soared by 34.06% to $13.0 million in 2026.
- Business Quant data shows TECX's Total Current Liabilities at $13.0 million in Q1 2026, $9.7 million in Q4 2025, and $9.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 1.70 Mn |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 636.40 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 13.42 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 3.88 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 72.86 Mn |
| 10 | Tectonic Therapeutic | 528.16 Mn | 291.27 Mn | - | 12.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.96 Mn |
| Dec 31, 2025 | 9.67 Mn |
| Sep 30, 2025 | 9.37 Mn |
| Jun 30, 2025 | 11.36 Mn |
| Mar 31, 2025 | 13.51 Mn |
| Dec 31, 2024 | 11.61 Mn |
| Sep 30, 2024 | 17.32 Mn |
| Jun 30, 2024 | 26.00 Mn |
| Mar 31, 2024 | 3.51 Mn |
| Dec 31, 2023 | 40.89 Mn |
| Sep 30, 2023 | 7.56 Mn |
| Jun 30, 2023 | 11.66 Mn |
| Mar 31, 2023 | 14.30 Mn |
| Dec 31, 2022 | 13.12 Mn |
| Sep 30, 2022 | 16.19 Mn |
| Jun 30, 2022 | 12.79 Mn |
| Mar 31, 2022 | 17.13 Mn |
| Dec 31, 2021 | 19.39 Mn |
| Sep 30, 2021 | 22.79 Mn |
| Jun 30, 2021 | 16.95 Mn |